Works matching IS 11732563 AND DT 2012 AND VI 32 AND IP 5
Results: 6
Absorption, Distribution, Metabolism and Excretion of [<sup>14</sup>C]Dexlansoprazole in Healthy Male Subjects.
- Published in:
- Clinical Drug Investigation, 2012, v. 32, n. 5, p. 319, doi. 10.2165/11630930-000000000-00000
- By:
- Publication type:
- Article
Management of Opioid-Induced Constipation in Cancer Patients.
- Published in:
- Clinical Drug Investigation, 2012, v. 32, n. 5, p. 293, doi. 10.2165/11598000-000000000-00000
- By:
- Publication type:
- Article
α<sub>1</sub>-Proteinase Inhibitor (Human) in the Treatment of Hereditary Emphysema Secondary to α<sub>1</sub>-Antitrypsin Deficiency.
- Published in:
- Clinical Drug Investigation, 2012, v. 32, n. 5, p. 354, doi. 10.2165/11631920-000000000-00000
- By:
- Publication type:
- Article
Effects of Bilastine on T-wave Morphology and the QTc Interval.
- Published in:
- Clinical Drug Investigation, 2012, v. 32, n. 5, p. 339, doi. 10.2165/11599270-000000000-00000
- By:
- Publication type:
- Article
Relative Bioavailability Study of a Novel Prodrug of Tenofovir, Tenofovir Dipivoxil Fumarate, in Healthy Male Fasted Volunteers.
- Published in:
- Clinical Drug Investigation, 2012, v. 32, n. 5, p. 333, doi. 10.2165/11599910-000000000-00000
- By:
- Publication type:
- Article
Besifloxacin Ophthalmic Suspension 0.6% Administered Twice Daily for 3 Days in the Treatment of Bacterial Conjunctivitis in Adults and Children.
- Published in:
- Clinical Drug Investigation, 2012, v. 32, n. 5, p. 303, doi. 10.2165/11632470-000000000-00000
- By:
- Publication type:
- Article